| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.33 | 6e-12 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-06 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-06 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |